Troutman Pepper advised Apnimed on the deal. Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA) and related...
Apnimed’s Series C Financing
Trevena’s Royalty-Based Financing Agreement with R-Bridge Healthcare Fund
Troutman Pepper advised Trevena on the deal. Trevena, a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system...